Für den Inhalt der Angaben zeichnet die Projektleitung verantwortlich.
Dieses von der Gebert Rüf Stiftung geförderte Projekt wird von folgenden weiteren Projektpartnern mitgetragen: Swiss Federal Institute of Technology (EPFL);
Centre Hospitalier Universitaire Vaudois (CHUV); Ecole d’Art de Lausanne (ECAL)
Project no: GRS-080/17
Amount of funding: CHF 71'000
Duration: 04.2018 - 06.2019
Area of activity: DesignPlus, 2013 - 2018
Ecole Polytechnique Fédérale de Lausanne
Laboratory of Microsystems 4
STI IMT LMIS4, Station 17
1015 Lausanne (Schweiz)
- david.bonzon@epfl. ch
With medical science progressing towards the next frontier of personalized medicine, the need for faster and efficient single cell isolation has become ever more important. Currently, single cell isolation processes are not traceable and companies use nearly 20 weeks in validating cell isolation. While many have tried to find more efficient ways, a team from the EPFL and CHUV have developed and patented an innovative method of single cell isolation based on impedance spectroscopy.
Together with the designers from the ECAL, we want to create a tool that simplifies processes, and the tool must be simple in itself. In fact, we have a complex distruptive technology at hand and the challenge is to deliver it in a form that is familiar and in the active memory of its users. If done right, it will not only provide a full solution for needs, help conserve resources of time and money, but also push the field of personalized medicine forward and be a flagbearer of Swiss innovation and design.
What is special about the project?
We believe that powerful things come in simple packages. Upon observing the working reality of the biologist in the lab, the team came up with the idea of integrating the new technology into the familiarity of a pipette, the extension of a biologist’s hands. The single cell dispensing pipette will enable scientists to isolate single cells with the simple push of a button. Through our project, we aim to make the experience of isolating single cells for biologists, as easy as point and click, and in effect making the tools that will push forward this century of biology.
The project is the fruit of 4 years of research, including two PhD theses on the matter. Recently a pilot project was started with the objective to build a prototype and proceed to feasibility studies. Contacts were made with key opinion leaders in regenerative medicine who confirmed the high market potential and also expressed their willing to test the prototype, once available. Therefore the time is apt to integrate design to complement and guide the engineering development.
No publication to date.
Persons involved in the project
Last update to this project presentation 09.07.2019